Page last updated: 2024-09-05

erlotinib hydrochloride and Fractures, Bone

erlotinib hydrochloride has been researched along with Fractures, Bone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Edeline, J; Frenel, JS; Gilabert, M; Raoul, JL; Senellart, H	1

Reviews

1 review(s) available for erlotinib hydrochloride and Fractures, Bone

Article	Year
[Proton pump inhibitors and cancers: A hazardous association?] Bulletin du cancer, 2020, Volume: 107, Issue:4 Topics: Antineoplastic Agents; Bacterial Infections; Capecitabine; Contraindications, Drug; Drug Interactions; Dysbiosis; Erlotinib Hydrochloride; Fractures, Bone; Gastrointestinal Absorption; Gastrointestinal Neoplasms; Gefitinib; Humans; Indazoles; Kidney; Neoplasms; Prognosis; Protein-Tyrosine Kinases; Proton Pump Inhibitors; Pyrimidines; Sulfonamides	2020

Article

Year

[Proton pump inhibitors and cancers: A hazardous association?]

Bulletin du cancer, 2020, Volume: 107, Issue:4

Topics: Antineoplastic Agents; Bacterial Infections; Capecitabine; Contraindications, Drug; Drug Interactions; Dysbiosis; Erlotinib Hydrochloride; Fractures, Bone; Gastrointestinal Absorption; Gastrointestinal Neoplasms; Gefitinib; Humans; Indazoles; Kidney; Neoplasms; Prognosis; Protein-Tyrosine Kinases; Proton Pump Inhibitors; Pyrimidines; Sulfonamides

2020